Europe
APEIRON Biologics AG announced that it will present its development program and data from ongoing preclinical studies of APN401.
Almac Pharma Services, part of the global contract pharmaceutical development and manufacturing organisation, the Almac Group, has announced the successful completion of three global regulatory GMP inspections across three facilities in the space of just two weeks.
GE Healthcare is partnering with multiple companies and academic institutions to develop a portfolio of targeted Positron Emission Tomography (PET) tracers to better predict and monitor patient response to immunotherapies.
Hutchison China MediTech Limited will showcase data from its proprietary clinical programs at the 2019 European Society for Medical Oncology Congress on September 27 to October 1, 2019 in Barcelona, Spain.
Ergomed plc,, a company focused on providing specialised services to the global pharmaceutical industry, announces that Peter George will step down from the Board with immediate effect to focus on his other business activities, in particular Benchmark Holdings plc where he was recently appointed Executive Chairman.
Ergomed plc, a company focused on providing specialised services to the global pharmaceutical industry, announces its unaudited interim results for the six months ended 30 June 2019.
Tacalyx announced that it has successfully secured €7 million in seed funding.
Biotech and pharma companies strengthen their leadership teams and boards of directors with this week’s appointments.
PARP inhibitors will be taking center stage at the European Society of Medical Oncology Congress as rival drugmakers aim to show off data that supports broader use of the drug in treating various cancers.
An investigational medicine in late-stage development by Jazz Pharmaceuticals hit the mark in treating cataplexy and excessive daytime sleepiness in adults with narcolepsy.
PRESS RELEASES